Impact of elexacaftor/tezacaftor/ivacaftor on geographic disparities in health outcomes for adults with cystic fibrosis in British Columbia
Abstract RATIONALE Prior research has demonstrated that people with cystic fibrosis (PwCF) in British Columbia (BC) had worse health outcomes if they traveled >360 min to reach their CF clinic compared to those who traveled shorter distances. The status of geographic disparities in CF has not been assessed since the in...